A Phase III, Open-Label, Single-Arm, Multicentric Study of Tildrakizumab in Indian Patients with Moderate-to-Severe Plaque Psoriasis.

Kumar S, Kumar S, Krishna V, Shivhare DP, Prasad PG, Kumar H, Mamidwar S, Pande S, Dhawan A, Patro N, Patel D, Shekar C, Parasramani S, Dogra S, Sonawane D, Patil D, Shaikh A, Pandit S, Ghadge P, Mehta S

Open source

DOI: 10.1007/s13555-026-01957-x
Published: 2026 Oct 26
Container: Dermatology and therapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01957-x,
  title = {A Phase III, Open-Label, Single-Arm, Multicentric Study of Tildrakizumab in Indian Patients with Moderate-to-Severe Plaque Psoriasis.},
  author = {Kumar S and Kumar S and Krishna V and Shivhare DP and Prasad PG and Kumar H and Mamidwar S and Pande S and Dhawan A and Patro N and Patel D and Shekar C and Parasramani S and Dogra S and Sonawane D and Patil D and Shaikh A and Pandit S and Ghadge P and Mehta S},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01957-x},
  url = {https://doi.org/10.1007/s13555-026-01957-x}
}

RIS

TY  - JOUR
TI  - A Phase III, Open-Label, Single-Arm, Multicentric Study of Tildrakizumab in Indian Patients with Moderate-to-Severe Plaque Psoriasis.
AU  - Kumar S
AU  - Kumar S
AU  - Krishna V
AU  - Shivhare DP
AU  - Prasad PG
AU  - Kumar H
AU  - Mamidwar S
AU  - Pande S
AU  - Dhawan A
AU  - Patro N
AU  - Patel D
AU  - Shekar C
AU  - Parasramani S
AU  - Dogra S
AU  - Sonawane D
AU  - Patil D
AU  - Shaikh A
AU  - Pandit S
AU  - Ghadge P
AU  - Mehta S
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01957-x
UR  - https://doi.org/10.1007/s13555-026-01957-x
ER  -

APA

S, K., S, K., V, K., DP, S., PG, P., H, K., S, M., S, P., A, D., N, P., D, P., C, S., S, P., S, D., D, S., D, P., A, S., S, P., P, G., & S, M. (2026). A Phase III, Open-Label, Single-Arm, Multicentric Study of Tildrakizumab in Indian Patients with Moderate-to-Severe Plaque Psoriasis.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01957-x

Source records

pubmed · retrieved 2026-11-10T12:12:30.739Z